(Q36695170)

English

Quantifying trade-offs: quality of life and quality-adjusted survival in a randomised trial of chemotherapy in postmenopausal patients with lymph node-negative breast cancer

scientific article published on November 2004

In more languages

default values for all languages

No label defined

No description defined

Statements

scholarly article

1 reference

Europe PubMed Central

PMC publication ID

15 August 2017

Quantifying trade-offs: quality of life and quality-adjusted survival in a randomised trial of chemotherapy in postmenopausal patients with lymph node-negative breast cancer (English)

1 reference

Europe PubMed Central

PMC publication ID

15 August 2017

author name string

J Bernhard

1

1 reference

Europe PubMed Central

PMC publication ID

15 August 2017

D Zahrieh

2

1 reference

Europe PubMed Central

PMC publication ID

15 August 2017

A S Coates

3

1 reference

Europe PubMed Central

PMC publication ID

15 August 2017

R D Gelber

4

1 reference

Europe PubMed Central

PMC publication ID

15 August 2017

M Castiglione-Gertsch

5

1 reference

Europe PubMed Central

PMC publication ID

15 August 2017

E Murray

6

1 reference

Europe PubMed Central

PMC publication ID

15 August 2017

J F Forbes

7

1 reference

Europe PubMed Central

PMC publication ID

15 August 2017

L Perey

8

1 reference

Europe PubMed Central

PMC publication ID

15 August 2017

J Collins

9

1 reference

Europe PubMed Central

PMC publication ID

15 August 2017

R Snyder

10

1 reference

Europe PubMed Central

PMC publication ID

15 August 2017

C-M Rudenstam

11

1 reference

Europe PubMed Central

PMC publication ID

15 August 2017

D Crivellari

12

1 reference

Europe PubMed Central

PMC publication ID

15 August 2017

A Veronesi

13

1 reference

Europe PubMed Central

PMC publication ID

15 August 2017

B Thürlimann

14

1 reference

Europe PubMed Central

PMC publication ID

15 August 2017

M F Fey

15

1 reference

Europe PubMed Central

PMC publication ID

15 August 2017

K N Price

16

1 reference

Europe PubMed Central

PMC publication ID

15 August 2017

A Goldhirsch

17

1 reference

Europe PubMed Central

PMC publication ID

15 August 2017

C Hürny

18

1 reference

Europe PubMed Central

PMC publication ID

15 August 2017

language of work or name

0 references

publication date

1 November 2004

1 reference

Europe PubMed Central

PMC publication ID

15 August 2017

British Journal of Cancer

1 reference

Europe PubMed Central

PMC publication ID

15 August 2017

91

1 reference

Europe PubMed Central

PMC publication ID

15 August 2017

11

1 reference

Europe PubMed Central

PMC publication ID

15 August 2017

1893-1901

1 reference

Europe PubMed Central

PMC publication ID

15 August 2017

Adjuvant breast cancer treatment and cognitive function: current knowledge and research directions

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2409769

30 September 2017

Sexual functioning in long-term breast cancer survivors treated with adjuvant chemotherapy

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2409769

30 September 2017

Progress in understanding fatigue associated with breast cancer treatment

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2409769

30 September 2017

Stability of patients' preferences for chemotherapy: the impact of experience

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2409769

30 September 2017

Patients' preferences for adjuvant chemotherapy in early-stage breast cancer: is treatment worthwhile?

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2409769

30 September 2017

Systematic overview of cost-utility assessments in oncology

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2409769

30 September 2017

Long-term quality of life in premenopausal women with node-negative localized breast cancer treated with or without adjuvant chemotherapy.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2409769

30 September 2017

Fatigue in breast cancer survivors: occurrence, correlates, and impact on quality of life

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2409769

30 September 2017

Defining clinical benefit in postmenopausal patients with breast cancer under second-line endocrine treatment: does quality of life matter?

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2409769

30 September 2017

Are health states "timeless"? The case of the standard gamble method

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2409769

30 September 2017

Subjective health estimations (SHE) in patients with advanced breast cancer: an adapted utility concept for clinical trials

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2409769

30 September 2017

Impact of adjuvant therapy on quality of life in women with node-positive operable breast cancer. International Breast Cancer Study Group

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2409769

30 September 2017

Do patients' evaluations of a future health state change when they actually enter that state?

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2409769

30 September 2017

Quality of life assessment in patients receiving adjuvant therapy for breast cancer: the IBCSG approach. The International Breast Cancer Study Group.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2409769

28 June 2018

The Perceived Adjustment to Chronic Illness Scale (PACIS): a global indicator of coping for operable breast cancer patients in clinical trials. Swiss Group for Clinical Cancer Research (SAKK) and the International Breast Cancer Study Group (IBCSG).

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2409769

28 June 2018

Costs and benefits of adjuvant therapy in breast cancer: a quality-adjusted survival analysis

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2409769

28 June 2018

On the receiving end. IV: Validation of quality of life indicators.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2409769

28 June 2018

Cancer patients' evaluations of their current health states: the influences of expectations, comparisons, actual health status, and mood.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2409769

28 June 2018

Quantitative assessment of changes in patients' constructs of quality of life: an application of multilevel models.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2409769

5 September 2018

A quality-adjusted survival (Q-TWiST) model for evaluating treatments for advanced stage cancer.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2409769

5 September 2018

Endocrine responsiveness and tailoring adjuvant therapy for postmenopausal lymph node-negative breast cancer: a randomized trial

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2409769

5 September 2018

Patient preferences for adjuvant chemotherapy of early breast cancer: how much benefit is needed?

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2409769

5 September 2018

Quality of life in long-term, disease-free survivors of breast cancer: a follow-up study

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2409769

5 September 2018

Response shift in the perception of health for utility evaluation. an explorative investigation

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2409769

5 September 2018

Tolerability of hormone therapies for breast cancer: how informative are documented symptom profiles in medical notes for 'well-tolerated' treatments?

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2409769

5 September 2018

Tamoxifen for the prevention of breast cancer: psychosocial impact on women participating in two randomized controlled trials

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2409769

5 September 2018

Quality of life after adjuvant chemotherapy for breast cancer.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2409769

5 September 2018

Assessing the performance of utility techniques in the absence of a gold standard.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2409769

5 September 2018

Quality adjusted survival analysis with repeated quality of life measures

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2409769

5 September 2018

Responsiveness of a single-item indicator versus a multi-item scale: assessment of emotional well-being in an international adjuvant breast cancer trial.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2409769

5 September 2018

The time trade-off technique: how do the valuations of breast cancer patients compare to those of other groups?

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2409769

5 September 2018

Eliciting preferences for alternative drug therapies in oncology: Influence of treatment outcome description, elicitation technique and treatment experience on preferences

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BJC.6602230

21 January 2018

The Validity of QALYs

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BJC.6602230

21 January 2018

Survey of breast cancer patients concerning their knowledge and expectations of adjuvant therapy

1 reference

https://pubmed.ncbi.nlm.nih.gov/15545973

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Quality of life and preferences for treatment following systemic adjuvant therapy for early-stage breast cancer

1 reference

https://pubmed.ncbi.nlm.nih.gov/15545973

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Quality of life and quality adjusted survival for breast cancer patients receiving adjuvant therapy. Eastern Cooperative Oncology Group (ECOG)

1 reference

https://pubmed.ncbi.nlm.nih.gov/15545973

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Visual analog scales: do they have a role in the measurement of preferences for health states?

1 reference

https://pubmed.ncbi.nlm.nih.gov/15545973

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Health-related quality of life and tamoxifen in breast cancer prevention: a report from the National Surgical Adjuvant Breast and Bowel Project P-1 Study

1 reference

https://pubmed.ncbi.nlm.nih.gov/15545973

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Unstable preferences: a shift in valuation or an effect of the elicitation procedure?

1 reference

https://pubmed.ncbi.nlm.nih.gov/15545973

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Timing of baseline quality of life assessment in an international adjuvant breast cancer trial: its effect on patient self-estimation. The International Breast Cancer Study Group

1 reference

https://pubmed.ncbi.nlm.nih.gov/15545973

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

The "utility" of the Time Trade-Off method in cancer patients: feasibility and proportional Trade-Off

1 reference

https://pubmed.ncbi.nlm.nih.gov/15545973

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Multiattribute utility function for a comprehensive health status classification system. Health Utilities Index Mark 2

1 reference

https://pubmed.ncbi.nlm.nih.gov/15545973

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Identifiers

10.1038/SJ.BJC.6602230

1 reference

Europe PubMed Central

PMC publication ID

15 August 2017

PMC publication ID

1 reference

Europe PubMed Central

PMC publication ID

15 August 2017

PubMed publication ID

1 reference

Europe PubMed Central

PMC publication ID

15 August 2017

ResearchGate publication ID

0 references

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q36695170&oldid=2199199011"